2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Lymphoma, Non-Hodgkin
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Colonic Neoplasms
4
Congenital Abnormalities
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Waldenstrom Macroglobulinemia
2
Somatostatinoma
2
Recurrence
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Colorectal Neoplasms
2
Carcinoma, Islet Cell
2
Vulvar Neoplasms
1
Vipoma
1
Vaginal Neoplasms
1
Interventions
pembrolizumab
3
Drug Therapy
3
Quality of Life
2
Proton Therapy
2
Immunotherapy
2
Blood Specimen Collection
2
ribociclib
1
palbociclib
1
napabucasin
1
fludarabine
1
epacadostat
1
bosutinib
1
amrubicin
1
alovudine
1
Tumor Burden
1
Sunitinib
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Plicamycin
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Histocompatibility Testing
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thymus Neoplasms
×
Biological Therapy
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled